KLOW Protocol (BPC-157 | TB-500 | GHK-Cu | KPV)
An Educational Overview of Recovery, Inflammation Support, and Skin & Tissue Repair
The KLOW protocol is designed to support tissue healing, inflammation control, and overall recovery at both the muscular and cellular level.
It combines peptides that are studied for their roles in tissue repair, skin health, and inflammation regulation.
This protocol overview is provided for educational purposes only and should not replace guidance from a licensed healthcare professional.
Understanding Recovery, Inflammation, and Tissue Repair
The body relies on coordinated biological processes to repair tissues, regulate inflammation, and maintain overall function.
The KLOW protocol combines compounds that support both localized healing and full-body recovery.
The primary components of this protocol are:
• BPC-157
• TB-500 (Thymosin Beta-4 Fragment)
• GHK-Cu (Copper Peptide)
• KPV
Purpose of the Protocol
This protocol is designed to support:
• Faster healing of muscles, tendons, and connective tissues
• Reduced inflammation and irritation in the body
• Improved skin health and tissue repair
• Support for recovery from injuries or intense physical activity
• Improved overall recovery and cellular repair
Who This Protocol May Be For
This protocol may be appropriate for individuals who:
• Are adults in generally good health
• Are recovering from injuries or physical strain
• Experience inflammation or joint discomfort
• Want support for skin health and tissue repair
• Are athletes or active individuals seeking faster recovery
Individuals with medical conditions should consult a healthcare professional before beginning any protocol.
Who Should NOT Use This Protocol
This protocol may not be appropriate for individuals who:
• Are pregnant or breastfeeding
• Have active infections or uncontrolled medical conditions
• Are undergoing medical treatment without supervision
• Have sensitivities to compounds affecting inflammation, recovery, or skin processes
Individuals who are unsure should consult a qualified healthcare professional before use.
Recommended Starting Health Checks
• Pain or discomfort levels
• Areas of inflammation or injury
• Skin condition and healing areas
• Mobility or range of motion
Treatment Plan Overview
Route: Subcutaneous (under the skin)
Areas: Abdomen, glute, or near affected area
Frequency: Daily or several times per week
Timing: Morning or evening
Duration: 4–6 weeks
Starting Phase
To allow the body time to adjust, begin with a low dose and increase gradually if needed.
Week 1:
• Start with 20 units (≈1–2mg depending on mix)
• Inject into glute or target area
• Monitor inflammation, recovery, and skin response
Week 2–4:
• Continue 20 units daily if effective
• Adjust frequency based on recovery response
Week 4–6:
• Continue until recovery goals are met
• Reduce frequency as symptoms improve
Dosing & Mixing Guide
Step 1: Mixing
• Add 3 mL of BAC water into the vial
• Let the powder fully dissolve (do not shake hard)
Step 2: Understanding Your Syringe
Use a U-100 insulin syringe (used for precise unit measurement).
The syringe is measured in units, not mg.
You will draw to a number on the syringe (example: 20 units).
These units equal your dose based on how the vial was mixed.
Step 3: How Much to Draw
• Standard KLOW blend → 20 units daily (1–2mg depending on concentration)
Optional GHK-Cu Adjustment:
• 25 units (1–2mg) every other day
• OR 10–15 units daily depending on protocol
If unsure, do not guess. Always double check before injecting.
Injection Guidelines
• Inject under the skin (subcutaneous)
• Best areas: glute, abdomen, or near affected area
• Use a small insulin syringe (29–31 gauge)
• Clean the injection site before use
• Rotate injection sites each time
Reconstitution Summary:
BAC Water: 2–3 mL
Syringe: U-100 insulin syringe (for precise unit measurement)
Storage: Keep refrigerated after reconstitution
Travel: If reconstituted, use a cooler or ice pack to keep cold
Progress Monitoring
Baseline (Before Starting):
• Pain levels
• Inflammation
• Skin condition
Week 2
• Evaluate inflammation reduction
• Assess mobility improvements
Week 4
• Review healing progress
• Assess physical recovery
Week 6
• Final evaluation of tissue healing
• Review skin health and overall recovery
Safety and Adjustments
• Injection site irritation → rotate injection locations
• Fatigue → ensure proper rest and hydration
• Changes in inflammation response → adjust schedule if needed